BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 21756998)

  • 1. Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease.
    Blalock EM; Buechel HM; Popovic J; Geddes JW; Landfield PW
    J Chem Neuroanat; 2011 Oct; 42(2):118-26. PubMed ID: 21756998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.
    Blalock EM; Geddes JW; Chen KC; Porter NM; Markesbery WR; Landfield PW
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2173-8. PubMed ID: 14769913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease.
    Ginsberg SD; Alldred MJ; Che S
    Neurobiol Dis; 2012 Jan; 45(1):99-107. PubMed ID: 21821124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective decline of neurotrophin and neurotrophin receptor genes within CA1 pyramidal neurons and hippocampus proper: Correlation with cognitive performance and neuropathology in mild cognitive impairment and Alzheimer's disease.
    Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Che S; Elarova I; Chen Y; Jeanneteau F; Kranz TM; Chao MV; Counts SE; Mufson EJ
    Hippocampus; 2019 May; 29(5):422-439. PubMed ID: 28888073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression.
    Ginsberg SD; Alldred MJ; Counts SE; Cataldo AM; Neve RL; Jiang Y; Wuu J; Chao MV; Mufson EJ; Nixon RA; Che S
    Biol Psychiatry; 2010 Nov; 68(10):885-93. PubMed ID: 20655510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Hippocampal Functional Connectivity Is Associated with Fornix White Matter Integrity in Alzheimer's Disease and Mild Cognitive Impairment.
    Wang P; Zhou B; Yao H; Xie S; Feng F; Zhang Z; Guo Y; An N; Zhou Y; Zhang X; Liu Y
    J Alzheimers Dis; 2020; 75(4):1153-1168. PubMed ID: 32390630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's disease.
    Salat DH; Chen JJ; van der Kouwe AJ; Greve DN; Fischl B; Rosas HD
    Neuroimage; 2011 Feb; 54(3):1795-802. PubMed ID: 20965261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling.
    Colangelo V; Schurr J; Ball MJ; Pelaez RP; Bazan NG; Lukiw WJ
    J Neurosci Res; 2002 Nov; 70(3):462-73. PubMed ID: 12391607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic analysis reveals sex-specific patterns in the hippocampus in Alzheimer's disease.
    Onisiforou A; Christodoulou CC; Zamba-Papanicolaou E; Zanos P; Georgiou P
    Front Endocrinol (Lausanne); 2024; 15():1345498. PubMed ID: 38689734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and beta-amyloid pathologies.
    Kelliher M; Fastbom J; Cowburn RF; Bonkale W; Ohm TG; Ravid R; Sorrentino V; O'Neill C
    Neuroscience; 1999; 92(2):499-513. PubMed ID: 10408600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.
    Elkahloun AG; Hafko R; Saavedra JM
    Alzheimers Res Ther; 2016 Jan; 8():5. PubMed ID: 26822027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model.
    Zerbi V; Kleinnijenhuis M; Fang X; Jansen D; Veltien A; Van Asten J; Timmer N; Dederen PJ; Kiliaan AJ; Heerschap A
    Neurobiol Aging; 2013 May; 34(5):1440-50. PubMed ID: 23273575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometry.
    Mendis LH; Grey AC; Faull RL; Curtis MA
    Brain Behav; 2016 Oct; 6(10):e00517. PubMed ID: 27781133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex.
    Dournaud P; Cervera-Pierot P; Hirsch E; Javoy-Agid F; Kordon C; Agid Y; Epelbaum J
    Neuroscience; 1994 Aug; 61(4):755-64. PubMed ID: 7838375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter.
    Wang WX; Huang Q; Hu Y; Stromberg AJ; Nelson PT
    Acta Neuropathol; 2011 Feb; 121(2):193-205. PubMed ID: 20936480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographic regulation of kinase activity in Alzheimer's disease brains.
    Grant P; Pant HC
    J Alzheimers Dis; 2002 Aug; 4(4):269-81. PubMed ID: 12446929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease.
    Hashimoto M; Bogdanovic N; Nakagawa H; Volkmann I; Aoki M; Winblad B; Sakai J; Tjernberg LO
    J Cell Mol Med; 2012 Aug; 16(8):1686-700. PubMed ID: 21883897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter pathology isolates the hippocampal formation in Alzheimer's disease.
    Salat DH; Tuch DS; van der Kouwe AJ; Greve DN; Pappu V; Lee SY; Hevelone ND; Zaleta AK; Growdon JH; Corkin S; Fischl B; Rosas HD
    Neurobiol Aging; 2010 Feb; 31(2):244-56. PubMed ID: 18455835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.
    Gómez Ravetti M; Rosso OA; Berretta R; Moscato P
    PLoS One; 2010 Apr; 5(4):e10153. PubMed ID: 20405009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.